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Alcohol and dementia: Implications of Alzheimer’s-like pathology 
in alcohol abuse
Natalie Swanson, Divya Thomas Chemparathy, Shilpa Buch, Susmita Sil
Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE
Alcohol use is widespread, with 85.6 percent of people ages 18 and older reported drinking alcohol in their lifetime in 2019. Mild to heavy alcohol use
is associated with multi-organ dysfunction at the cellular and genetic levels, as well as epigenetic modifications, leading to liver and brain damage and
dementia. The role of astrocytes as contributors to Alzheimer’s like pathology associated with cognitive decline in opiate abusers and people with HIV-
associated neurological disorders (HAND) has been recently reported from our group. We hypothesize that alcohol could also induce astrocytic
amyloidosis. In this study we demonstrated that exposure of human primary astrocytes (HPA) to ethanol resulted in a dose dependent (6.25-200 mM)
increase in AD markers-amyloid precursor protein (APP), Aβ 1-42, β-site cleaving enzyme (BACE1), as well as the inflammatory marker IL1β and lncRNA
BACE1AS. Next, we demonstrated a time-dependent (0-96h, 12.5 mM) upregulation of AD markers, oxidative stress (4-HNE), alcohol metabolizing
enzymes alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH2), and cytochrome P450 2E1 (CYP2E1), as well as proinflammatory cytokines
(TNF-α, IL1β, IL6) in HPAs exposed to alcohol. Gene silencing approaches confirmed the regulatory role of lncRNA BACE1-AS in amyloidosis and its
interaction with alcohol metabolic pathways leading to neuroinflammation and oxidative stress. Further, in vivo study validated our in vitro findings,
demonstrating up-regulation of APP, Aβ1-42, 4-HNE and IL1β in the cortices of ethanol-fed mice (4- weeks, ad libidum) compared to saline controls. This
is the first report implicating the role of lncRNA BACE-AS in alcohol-mediated induction of astrocytic amyloidosis, leading to neuroinflammation and
oxidative stress, which, in turn, could contribute to cognitive impairments. These findings set the stage for future development of therapeutic strategies
aimed at targeting cognitive deficits in alcohol users and abusers.
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Time dependent effects of Ethanol on Alzheimer’s like pathology in astrocytes
Time dependent effects of Ethanol on alcohol metabolism in astrocytes










Ø Ethanol exposed HPAs dose-dependently increased AD markers- amyloid precursor protein (APP), Aβ 1-42, and BACE1,
as well as inflammatory cytokine IL1β and lncRNA BACE1AS.
Ø Ethanol exposed HPAs time-dependently increased AD markers, oxidative stress- 4-HNE, alcohol metabolizing enzymes-
alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH2), and cytochrome P450 2E1 (CYP2E1) as well as
proinflammatory cytokines (TNF-α, IL1β, IL6)
Ø Gene silencing approaches confirmed the regulatory role of lncRNA BACE1-AS in astrocytic amyloidosis and its interaction
with mediators of alcohol metabolic pathways, leading to neuroinflammation and oxidative stress
Ø Ethanol-fed mice (4 weeks, ad libitum) demonstrated up-regulation of APP, Aβ1-42, 4-HNE and IL1β in the cortices
compared to saline controls.
Ø This is the first report implicating the role of lncRNA BACE-AS in alcohol-mediated induction of astrocytic amyloidosis,
leading, in turn, to neuroinflammation and oxidative stress, contributors of cognitive impairments.
Alcohol use leads to upregulated 
expression of lncRNA BACE1-AS, 
neurotoxic amyloids, and dysregulated 
alcohol metabolism, ultimately leading to 
increased brain oxidative stress burden,  
neuroinflammation, and associated 
cognitive impairments.
Ø Role of each CNS cell type in the contribution of Alzheimer’s like pathology in alcohol abuse.
Ø Role of acute, chronic and binge drinking on neurological disorders.
Ø Role of alcohol metabolizing enzymes and end products in AD phenotype and inflammation.
Ø Epigenetic modifications associated with alcohol abuse leading to cognitive disability.
Ø Combinatorial effects with other drugs of abuse.
Figure 1. Ethanol induced dose response changes in human primary astrocytes (HPA): Alcohol induces mRNA expression of APP,  BACE1, BACE1AS 
and IL1B by qRT-PCR (A). Representative western blot images for the protein expression of APP,  Aβ 1-42, BACE1, and IL1B (B). Data are expressed as 
mean + SEM. n= 3. Statistics: One Way ANOVA followed by Bonferroni post hoc test in Graphpad Prism software (Version 6).
Figure 2. Ethanol induced time dependent changes in in HPA. Alcohol induces mRNA expression of APP, BACE1, BACE1AS, TNF-α, IL1B, and IL-6
by qRT-PCR (A). Representative western blot images for the protein expression of APP, Aβ 1-42, BACE1, and IL1B (B). Representative
immunocytochemistry images demonstrating increased Aβ 1-42 expression ethanol exposed HPA compared to control (C), scale bar: 10 µm. Data are
expressed as mean + SEM. Statistics: n= 3. One Way ANOVA followed by Bonferroni post hoc test in Graphpad Prism software (Version 6).
Figure 3. Ethanol induced time dependent changes in alcohol metabolism in HPA. Representative western blot images for the protein expression of
Alcohol Dehydrogenase (ADH), Aldehyde Dehydrogenase 2 (ALDH2), cytochrome P450 2E1 (CYP2E1), and 4-HNE (4- hydroxynonenal). Data are
expressed as mean + SEM. Statistics: One Way ANOVA followed by Bonferroni post hoc test in Graphpad Prism software (Version 6).
Figure 4. Silencing of lncRNABACE1-AS inhibits alcohol-induced upregulation of Alzheimer’s like pathology and dysregulated alcohol
metabolism. Silencing of BACE1-AS long noncoding RNA inhibits alcohol-induced mRNA upregulation of APP, BACE1, BACE1AS, TNF-α, IL1B, and IL-6
by qRT-PCR (A). Representative western blot images for the protein expression of APP, Aβ 1-42, BACE1, 4-HNE, ADH, ALDH2, and IL1B in scrambled and
BACE1AS silenced cells. Data are expressed as mean + SEM. n=3. Statistics: One Way ANOVA followed by Bonferroni post hoc test in Graphpad Prism
software (Version 6).
Figure 5. Invivo validation of Ethanol induced Alzheimer’s like pathology in mice. Ethanol induced protein expression of APP (A), Aβ (B), 4-HNE (D),
and mIL-1β (E), in the cortex compared to saline. No significant changes in the expression of p-Tau was observed between saline and ethanol groups (C).
Data are expressed as mean + SEM. n= 7/ group. Statistics: Unpaired student’s t- test in Graphpad Prism software (Version 6).
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Ø According to the 2019 National Survey on Drug Use and Health, 85.6 percent of people aged 18 and older reported drinking alcohol in their lifetime and
25.8 percent reported binge drinking in the past month (SAMHSA, 2019).
Ø In a 25-year longitudinal study, binge drinking was associated with an odds ratio of 3.9 for dementia
(Jarvenpaa et. al., 2005), additionally, light to moderate alcohol consumption was also linked with
lower levels of dementia (Sabia, 2018) and amyloid buildup in the cerebrum of the
brain (Kim et al., 2019).
Ø Previous studies demonstrate potential links between alcohol and Alzheimer’s Disease (AD) e.g a
recent study have shown that alcohol exposure to microglia resulted in reduction of it’s phagocytic
activity to remove amyloids, resulting in microglial activation and inflammation (Kalinin, 2018).
Ø Long noncoding RNAs (lncRNA) are involved in epigenetic, transcriptional, post-
transcriptional, translational and posttranslational modification contributing to various neurological
disorders including alcohol use disorder and dependence (McMichael et al., 2019) as well as AD 
(Luo et al., 2016).
Ø BACE1 antisense (BACE1AS) long noncoding RNA has been reported to facilitate amyloid produc
tion via regulation of BACE1 in AD (Zeng et al., Li et al., 2019), as well as recent reports from our
lab has shown its role in AD pathology in HIV (Sil et al., 2020).
Ø Legal limits of alcohol in US is 0.08 gm% = 17 mM. 4 glasses of wine/ beer equivalent to ~ 10 mM
alcohol concentration in blood (Koob et al., 2014).
In the present study we assessed the role of alcohol in AD like phenotype leading to cognitive impairments,                                                                               
and the potential role of BACE1AS in this process.
v
Hypothesis
Ethanol exposure to astrocytes results in upregulated expression of lncRNA BACE1-AS, increased  amyloidosis and dysregulated alcohol 
metabolism, ultimately culminating in increased oxidative stress, neuroinflammation and accompanying cognitive impairment.
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